Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · IEX Real-Time Price · USD
11.00
-0.11 (-0.99%)
At close: Jul 19, 2024, 4:00 PM
11.43
+0.43 (3.91%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Roivant Sciences Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Roivant Sciences stock have an average target of 17.33, with a low estimate of 12 and a high estimate of 23. The average target predicts an increase of 57.55% from the current stock price of 11.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ROIV stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +100.00% | Jul 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +63.64% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +63.64% | Apr 22, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +63.64% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
173.99M
from 124.80M
Increased by 39.42%
Revenue Next Year
284.03M
from 173.99M
Increased by 63.25%
EPS This Year
-1.10
from 5.23
EPS Next Year
-1.19
from -1.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 260.4M | 407.8M | 1.2B | 2.4B | 4.1B |
| Avg | 174.0M | 284.0M | 659.6M | 1.5B | 2.6B |
| Low | 119.1M | 192.1M | 209.7M | 853.6M | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 108.6% | 134.4% | 319.7% | 259.3% | 165.5% |
| Avg | 39.4% | 63.2% | 132.2% | 133.2% | 67.5% |
| Low | -4.6% | 10.4% | -26.2% | 29.4% | -2.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.92 | -0.90 | -0.32 | 0.74 | 2.10 |
| Avg | -1.10 | -1.19 | -0.77 | 0.71 | 2.04 |
| Low | -1.33 | -1.49 | -1.19 | 0.69 | 1.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 194.1% |
| Avg | - | - | - | - | 185.7% |
| Low | - | - | - | - | 174.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.